The role of mitochondrial dynamics in metabolic dysfunction–associated steatotic liver disease - Takeaways - MDSpire

The role of mitochondrial dynamics in metabolic dysfunction–associated steatotic liver disease

  • By

  • Ningxi Yang

  • Yarong Hao

  • May 13, 2026

  • 0 min

Share

  • 1

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease linked to systemic metabolic disorders.

  • 2

    MASLD encompasses conditions from simple fatty liver to severe outcomes like cirrhosis and hepatocellular carcinoma.

  • 3

    Mitochondrial dynamics, involving fusion and fission, are crucial for mitochondrial function and play a significant role in MASLD pathogenesis.

  • 4

    Disruptions in mitochondrial dynamics contribute to the progression of MASLD, highlighting the need for effective therapeutic strategies.

  • 5

    Research into mitochondrial quality control mechanisms may provide novel insights for preventing and treating MASLD.

Original Source(s)

The role of mitochondrial dynamics in metabolic dysfunction–associated steatotic liver disease

  • by Ningxi Yang, Yarong Hao

  • May 13, 2026

Related Content

Management of MASLD/MASH: challenges, innovations, and the future of patient-centered care in Japan

Borderline Liver Enzyme Patterns and Their Metabolic–Inflammatory Signatures: An Observational Outpatient Study

Proteins at the intersection of circadian rhythms and metabolic dysfunction-associated steatotic liver disease: an 18-protein panel as a novel predictive biomarker set